Combined Technologies for the Life Sciences Industry

Manufacturing complex molecules (either advanced intermediates or APIs) often requires several steps, integrating and combining purification processes and synthesis routes.

Thanks to the large range of complementary expertise and technologies mastered by its companies, Groupe Novasep is able to design and optimize both purification processes and synthesis routes in order to produce such molecules.

This combination of competences makes Groupe Novasep unique and able to offer integrated and global solutions to its customers from the life science industries.

Numerous examples can be given from Groupe Novasep's portfolio and "toolbox":

Combining purification and synthesis

Novasep is able to combine chromatographic purification with multi-step synthesis in its five FDA-inspected sites. Whether you decide to in-source or out-source your production, Novasep will provide the right combination of purification and synthesis technologies and find your solution.

Proprietary HPAIs production

A perfect example is the manufacturing of semi-synthetic Paclitaxel, a major High Potent Active Ingredient used in several cancer treatments, produced by Groupe Novasep.

This production requires the combination/integration of several technologies such as extraction, chromatography, crystallization, and several chemical steps. All this expertise can be found within Groupe Novasep.

Chiral applications

Combining synthesis with purification technologies to produce chiral APIs and intermediates in FDA inspected sites, from lab to industrial scale. (See technologies / chiral technologies)

Early stage services

Supplying and combining fast synthesis and purification from milligrams to kilograms quantities, to give fast access to pure compounds in preclinical and early clinical phases. (See Exclusive Synthesis / early stage services)

Combining Purification Technologies

Downstream Processing

Offering a combination of preparative LPLC,MPLC, HPLC, filtration membranes and more to purify biopharmaceuticals (vaccines, therapeutic proteins, mAbs.). (See biopharma/products and services.)

Coupling Chromatography and Crystallization

Integrating complementary purification technologies for a global purification process optimization. (See coupling Chromatography and crystallization)